In its comments, AHIP argues that the agencies should establish “more, rather than less, review” and calls upon the FTC and DOJ to lower its safety zone thresholds.
The AHIP states that providers and insurers have established numerous ACO-like arrangements for some time without any additional antitrust protections, suggesting additional protections for Medicare ACOs may be unnecessary.
AHIP worries relaxed antitrust regulations may encourage further consolidation, which has been shown by studies drive up healthcare costs, in some cases.
Read AHIP’s comments on ACO antitrust guidelines (pdf).
Related Articles on ACO Antitrust Issues:
ACOs: 5 Tips to Avoid Anticompetitive Behavior
AHA Issues Response to Proposed ACO Antitrust Policy, Urges IRS to Offer Guidance
AMA Issues Response to Proposed ACO Antitrust Policy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
